HMMR and breast cancer: For example, hemizygous deletion of HMMR is present in almost half of malignant peripheral nerve sheath tumors [74,75]; HMMR expression is diminished in 96% of human seminomas [50]; and, germline HMMR variants that associate with lower expression also associate with increased breast cancer risk in some patient cohorts [61,76,77].